142 related articles for article (PubMed ID: 27777219)
1. Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate Cancer.
Kilpeläinen TP; Talala K; Raitanen J; Taari K; Kujala P; Tammela TLJ; Auvinen A
Am J Epidemiol; 2016 Nov; 184(10):720-731. PubMed ID: 27777219
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer mortality in the Finnish randomized screening trial.
Kilpeläinen TP; Tammela TL; Malila N; Hakama M; Santti H; Määttänen L; Stenman UH; Kujala P; Auvinen A
J Natl Cancer Inst; 2013 May; 105(10):719-25. PubMed ID: 23479454
[TBL] [Abstract][Full Text] [Related]
3. Number of Screening Rounds and Postscreening Prostate Cancer Incidence: Results from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer Study.
Pakarainen T; Raitanen J; Talala K; Taari K; Kujala P; Tammela TL; Auvinen A
Eur Urol; 2016 Sep; 70(3):499-505. PubMed ID: 27210461
[TBL] [Abstract][Full Text] [Related]
4. Impact of Prostatic-specific Antigen Threshold and Screening Interval in Prostate Cancer Screening Outcomes: Comparing the Swedish and Finnish European Randomised Study of Screening for Prostate Cancer Centres.
Saarimäki L; Hugosson J; Tammela TL; Carlsson S; Talala K; Auvinen A
Eur Urol Focus; 2019 Mar; 5(2):186-191. PubMed ID: 28803925
[TBL] [Abstract][Full Text] [Related]
5. Number of screening rounds attended and incidence of high-risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC).
Pakarainen T; Nevalainen J; Talala K; Taari K; Raitanen J; Kujala P; Stenman UH; Tammela TLJ; Auvinen A
Cancer; 2021 Jan; 127(2):188-192. PubMed ID: 33048394
[TBL] [Abstract][Full Text] [Related]
6. Results of the three rounds of the Finnish Prostate Cancer Screening Trial--the incidence of advanced cancer is decreased by screening.
Kilpeläinen TP; Auvinen A; Määttänen L; Kujala P; Ruutu M; Stenman UH; Tammela TL
Int J Cancer; 2010 Oct; 127(7):1699-705. PubMed ID: 20473861
[TBL] [Abstract][Full Text] [Related]
7. The impact of socioeconomic status on stage specific prostate cancer survival and mortality before and after introduction of PSA test in Finland.
Seikkula HA; Kaipia AJ; Ryynänen H; Seppä K; Pitkäniemi JM; Malila NK; Boström PJ
Int J Cancer; 2018 Mar; 142(5):891-898. PubMed ID: 29044563
[TBL] [Abstract][Full Text] [Related]
8. The Finnish prostate cancer screening trial: analyses on the screening failures.
Kilpeläinen TP; Tammela TL; Malila N; Hakama M; Santti H; Määttänen L; Stenman UH; Kujala P; Auvinen A
Int J Cancer; 2015 May; 136(10):2437-43. PubMed ID: 25359457
[TBL] [Abstract][Full Text] [Related]
9. Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial.
van Leeuwen PJ; Kranse R; Hakulinen T; Hugosson J; Tammela TL; Ciatto S; Roobol MJ; Zappa M; de Koning HJ; Bangma CH; Moss SM; Auvinen A; Schröder FH
J Med Screen; 2013 Mar; 20(1):33-38. PubMed ID: 28075228
[TBL] [Abstract][Full Text] [Related]
10. Update of the results of the Spanish branch of the European Randomized Study on Screening for Prostate Cancer (ERSPC).
Luján M; Páez Á; Angulo JC; Andrés G; Gimbernat H; Redondo C; Torres GM; Berenguer A
Actas Urol Esp; 2015 Sep; 39(7):405-13. PubMed ID: 25777669
[TBL] [Abstract][Full Text] [Related]
11. Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.
van Leeuwen PJ; Otto SJ; Kranse R; Roobol MJ; Bul M; Zhu X; de Koning H; Schröder FH
BJU Int; 2012 Jul; 110(2):188-94. PubMed ID: 22288823
[TBL] [Abstract][Full Text] [Related]
12. A population-based study of the influence of socioeconomic status on prostate cancer diagnosis in Taiwan.
Wu CC; Lin CH; Chiang HS; Tang MJ
Int J Equity Health; 2018 Jun; 17(1):79. PubMed ID: 29903010
[TBL] [Abstract][Full Text] [Related]
13. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia.
Ndubuisi SC; Kofie VY; Andoh JY; Schwartz EM
Urology; 1995 Jul; 46(1):71-7. PubMed ID: 7604479
[TBL] [Abstract][Full Text] [Related]
14. The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC).
Pakarainen T; Nevalainen J; Talala K; Taari K; Raitanen J; Kujala P; Stenman UH; Tammela TLJ; Auvinen A
Clin Cancer Res; 2019 Jan; 25(2):839-843. PubMed ID: 30322875
[TBL] [Abstract][Full Text] [Related]
15. Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.
Gulati R; Feuer EJ; Etzioni R
Am J Epidemiol; 2016 Jul; 184(2):140-7. PubMed ID: 27358266
[TBL] [Abstract][Full Text] [Related]
16. Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial.
van Leeuwen PJ; Kranse R; Hakulinen T; Hugosson J; Tammela TL; Ciattoy S; Roobol MJ; Zappa M; de Koning HJ; Bangma CH; Moss SM; Auvinen A; Schröder FH
J Med Screen; 2013 Mar; 20(1):33-8. PubMed ID: 23390203
[TBL] [Abstract][Full Text] [Related]
17. Family history in the Finnish Prostate Cancer Screening Trial.
Saarimäki L; Tammela TL; Määttänen L; Taari K; Kujala PM; Raitanen J; Auvinen A
Int J Cancer; 2015 May; 136(9):2172-7. PubMed ID: 25274038
[TBL] [Abstract][Full Text] [Related]
18. Bias-corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: Analysis of the Finnish randomized study of screening for prostate cancer.
Lindberg A; Talala K; Kujala P; Stenman UH; Taari K; Kilpeläinen TP; Tammela TL; Auvinen A
Int J Cancer; 2019 Aug; 145(3):632-638. PubMed ID: 30653262
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer.
Rundle A; Neckerman KM; Sheehan D; Jankowski M; Kryvenko ON; Tang D; Rybicki BA
Cancer Causes Control; 2013 Feb; 24(2):297-303. PubMed ID: 23224323
[TBL] [Abstract][Full Text] [Related]
20. Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer.
Walter SD; Hu J; Talala K; Tammela T; Taari K; Auvinen A
Cancer Causes Control; 2021 Nov; 32(11):1299-1313. PubMed ID: 34313874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
